Rich TV speaks with John Arbuthnot, CEO of Canadian cannabis Company Delta 9 Inc. (TSX: DN, OTCQX: VRNDF, Forum) about the state of the cannabis industry and the future of some of its main products (flower, pre-rolls, topical and edibles) going forward. Later this fall, the Company is moving into the vaporizer space.
Having just released its Q2 2019 financial results, Delta 9 reported $8.9 million in top-line revenue, up from the year prior.
Delta 9 is engaged in Biotechnology and Medical Research. The Company is a licensed producer of medical marijuana and operates a production facility in Winnipeg, Manitoba. It has three categories of cannabis such as Indica, Sativa, and Hybrid.